2nd Quarter - Report

AMERICAN OSTEOPATHIC ASSOCIATION for AMERICAN OSTEOPATHIC ASSOCIATION

Firm
Client
Income
—
Expenses
$286,075
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

9 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Recognition of Osteopathic Certification

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Health & Human Services, Dept of (HHS); White House Office; Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Health Resources & Services Administration (HRSA)

Budget/Appropriations BUD

National Health Service Corps; Community Health Centers; Health Resource & Services Administration

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Executive Office of the President (EOP); Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); White House Office; HOUSE OF REPRESENTATIVES; Government Accountability Office (GAO); Medicare Payment Advisory Commission (MedPAC); Centers For Medicare and Medicaid Services (CMS)

Insurance INS

Professional Liability Insurance; Health Insurance

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: White House Office; Office of Management & Budget (OMB); Agency for Healthcare Research & Quality (AHRQ); Health Resources & Services Administration (HRSA); SENATE; Centers For Medicare and Medicaid Services (CMS); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Centers For Disease Control & Prevention (CDC); Government Accountability Office (GAO)

Torts TOR

Medical Liability Reform; Protecting Access to Care Act; Good Samaritan Health Professionals Act

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); White House Office; Government Accountability Office (GAO); Centers For Disease Control & Prevention (CDC); Centers For Medicare and Medicaid Services (CMS); Health Resources & Services Administration (HRSA); Food & Drug Administration (FDA); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); SENATE; Medicare Payment Advisory Commission (MedPAC); Office of Management & Budget (OMB)

Taxation/Internal Revenue Code TAX

Health Savings Accounts; Primary Care Enhancement Act

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Office of Management & Budget (OMB); SENATE; White House Office; Health Resources & Services Administration (HRSA); Centers For Disease Control & Prevention (CDC); Medicare Payment Advisory Commission (MedPAC); Food & Drug Administration (FDA); Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Agency for Healthcare Research & Quality (AHRQ); Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES

Health Issues HCR

Medicare Physician Payment Reform; Physician Workforce

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Agency for Healthcare Research & Quality (AHRQ); Food & Drug Administration (FDA); White House Office; Medicare Payment Advisory Commission (MedPAC); SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Centers For Disease Control & Prevention (CDC)

Medicare/Medicaid MMM

Graduate Medical Education; Resident Physician Shortage Act; Independent Payment Advisory Board (IPAB)

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Government Accountability Office (GAO); Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB); Centers For Disease Control & Prevention (CDC); White House Office; Agency for Healthcare Research & Quality (AHRQ); Medicare Payment Advisory Commission (MedPAC); HOUSE OF REPRESENTATIVES; Health Resources & Services Administration (HRSA); Health & Human Services, Dept of (HHS); SENATE; Food & Drug Administration (FDA); Executive Office of the President (EOP)

Education EDU

Teaching Health Center Graduate Medical Education; National Health Service Corps; Foreign Medical School Accountability Fairness Act; Single Accreditation

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. VP Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Office of Management & Budget (OMB); Food & Drug Administration (FDA); White House Office; Agency for Healthcare Research & Quality (AHRQ); Centers For Disease Control & Prevention (CDC); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Health & Human Services, Dept of (HHS); Health Resources & Services Administration (HRSA); Executive Office of the President (EOP); Medicare Payment Advisory Commission (MedPAC); Government Accountability Office (GAO)

Medical/Disease Research/Clinical Labs MED

NIH; FDA

LobbyistCovered position, as disclosed
LAUREN LATTANY Assistant Director of Congressional Affairs
DAVID PUGACH New Sr. Vice President, Public Policy
JOHN MICHAEL C. VILLARAMA Director of Congressional Affairs

Contacted: Health Resources & Services Administration (HRSA); White House Office; Centers For Medicare and Medicaid Services (CMS); SENATE; Agency for Healthcare Research & Quality (AHRQ); Government Accountability Office (GAO); Office of Management & Budget (OMB); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Medicare Payment Advisory Commission (MedPAC); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.